Skip to main content
. 2021 Dec 14;7(3):436–443. doi: 10.1016/j.ekir.2021.12.013

Figure 2.

Figure 2

eGFR over time in participants with and without MRA use at baseline. (a) With MRA use at baseline. (b) Without MRA use at baseline. eGFR, estimated glomerular filtration rate; LS, least-squared; MRA, mineralocorticoid receptor antagonist.